KORU Medical Systems, Inc.

NASDAQ:KRMD

Medical - Instruments & Supplies

Healthcare
$3.45 +1.55%

+$0.06 today

Market cap
$149.64M
Beta
0.42
P/E (TTM)
-80.2
EPS (TTM)
-$0.05
52W Low $2.91High $6.61

Volume 0.19M

Average 0.13M

KRMD Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

KORU Medical Systems, Inc.NASDAQ: KRMD

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 59.8%

Gross margin was 59.8% in Q1 FY2026, down 3.0 pp from a year earlier. On a trailing-twelve-month basis it was 61.5%, down 2.0 pp year over year. Over 3 fiscal years it widened by 7.2 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
59.8%-2.8 pp QoQ
Last fiscal yearDec 2025
62.3%-1.1 pp YoY
LTMMar 2026
61.5%-2.0 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-3.0 pp——
1 year-1.1 pp——
3 years+7.2 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
62.3%
Year-over-year change
-1.1pp

Gross Margin vs competitors

How KRMD compares with its peers on the latest reported figures

  • KRMD's LTM Mar 2026 gross margin of 61.5% is the 4th highest of the 10 companies compared; the peer median is 56.7%.
  • Its year-over-year change of -2.0 pp is the 7th highest of 10, against a peer median of -0.5 pp.
  • Over three fiscal years its change of +7.2 pp compares with a peer median of +0.9 pp.
KRMD Competitors Peer median
Gross Margin for KRMD and competitors
Company Period LTM level YoY 3-year change
TLSITriSalus Life Sciences, Inc.LTM Mar 202685.1% -0.5 pp+2.8 pp
MXCTMaxCyte, Inc.LTM Mar 202680.7% -0.2 pp-7.3 pp
PROFProfound Medical Corp.LTM Mar 202671.1% +4.4 pp+25.6 pp
KRMDKORU Medical Systems, Inc.LTM Mar 202661.5% -2.0 pp+7.2 pp
PREPrenetics Global LimitedLTM Mar 202658.3% +12.7 pp+25.3 pp
INFUInfuSystem Holdings, Inc.LTM Mar 202656.7% +3.6 pp+0.9 pp
UTMDUtah Medical Products, Inc.LTM Mar 202653.6% -2.1 pp-10.0 pp
NYXHNyxoah S.A.LTM Mar 202648.3% -17.2 pp+0.4 pp
STIMNeuronetics, Inc.LTM Mar 202648.0% -15.6 pp-27.8 pp
OSUROraSure Technologies, Inc.LTM Mar 202641.0% -1.5 pp+3.6 pp
Peer median (excluding KRMD) 56.7%-0.5 pp+0.9 pp

Competitors are the stored peer set for KRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue23.49M27.9M28.52M33.65M41.13M
Cost of Revenue9.72M12.53M11.81M12.31M15.52M
Gross Profit13.77M15.37M16.71M21.33M25.6M
Gross Margin58.6%55.1%58.6%63.4%62.3%
Research & Development2.47M4.96M5.74M5.26M4.39M
Selling, General & Admin000023.38M
Operating Expenses20.8M26.15M26.98M27.78M28.58M
Depreciation & Amortization463.13K587.14K870.39K772.89K810.5K
EBITDA(5.9M)(10.09M)(8.9M)(5.29M)(1.81M)
EBITDA Margin-25.1%-36.2%-31.2%-15.7%-4.4%
Operating Income(7.03M)(10.78M)(10.27M)(6.45M)(2.97M)
Operating Margin-29.9%-38.6%-36.0%-19.2%-7.2%
Interest Income13.08K145.59K561.33K444.64K293.4K
Interest Expense00000
Other Income / Expenses665.09K105.71K496.4K382.49K356.41K
Income Before Tax(6.36M)(10.68M)(9.77M)(6.06M)(2.62M)
Pre-Tax Margin-27.1%-38.3%-34.3%-18.0%-6.4%
Income Tax Expense(1.8M)(2.01M)3.97M2.89K21.89K
Net Income(4.56M)(8.66M)(13.74M)(6.07M)(2.64M)
Net Margin-19.4%-31.0%-48.2%-18.0%-6.4%
EPS (Basic)(0.10)(0.19)(0.30)(0.13)(0.06)
EPS (Diluted)(0.10)(0.19)(0.30)(0.13)(0.06)
Weighted Avg Shares44.39M45M45.6M45.8M46.19M
Weighted Avg Shares (Diluted)44.39M45M45.6M45.8M46.19M

KORU Medical Systems, Inc.

NASDAQ:KRMD

Intrinsic Alpha fair value

Locked

Current Price

$3.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.